Infra Stock Jumps 7% After It Secures ₹3,000 Cr Pharma Park Project in Maharashtra

Synopsis: An infrastructure company in focus after it secured a major long-term development project in Maharashtra focused on building a large integrated park for the life sciences and pharmaceutical sector. 

The shares of this infrastructure company majorly engaged in the business of construction, infrastructure development and management, jumped upto 7 percent after its subsidiary bags Pharma Park project 

With the market capitalization of Rs. 3255 Crores, the shares of Ramky Infrastructure reached an intraday high of Rs. 489 per share, raising nearly 7 percent from its previous day close of Rs. 458.55 per share and are trading at a P/E of 14.6 whereas industry P/E stands at 15.1 

What is the NEWS: 

Ramky Infrastructure Limited has announced that its wholly owned subsidiary company Maha Integrated Life Sciences City Limited (MILeS) has entered a concession agreement with the Maharashtra Industrial Development Corporation to design, develop, operate, and maintain a High Tech Pharmaceutical Park in the Dighi Port Industrial area in the Raigad district of Maharashtra on a PPP model.

The project will be executed on a budget of Rs. 3,000 crore. The concession agreement will be for a period of 95 years, which will include a construction period of 5 years and a maintenance period of 90 years. 

The project will also entail the development of an industrial park  on an area of 1,000 hectares with areas for industries as well as commercial facilities. The project will generate revenue for the company from the premiums received for the sale of land, development charges, income from the maintenance of the project, and income from the operation of the utilities.

About the company and Financials: 

Ramky Infrastructure Limited majorly engaged in the business of construction, infrastructure development and management which has been into these businesses for the last 3 decades. The company’s key business verticals includes Urban solutions, Building, Industrial, solutions, Water & Waste water treatment. The company has successfully completed close to 450 projects across all the sectors and 185 projects in the water sector and 50 in industries. The company’s order book as of Q3 FY26 stands at Rs. 8500 Crores with net debt almost close to nil. 

Year on Year analysis: Revenue from operations has increased from Rs. 459 Crores to Rs. 489 Crore, up 6.5 percent. Operating profit has decreased  from Rs. 90 Crores to Rs. 76 Crores, down 15.5 percent and net profit has increased from Rs. 60 Crores to Rs. 78 Crores, up 30 percent 

Quarter on Quarter analysis: Revenue from operations has increased from Rs. 472 Crores to Rs. 489 Crores, up 3.6 percent. Operating profit has decreased  from Rs. 83 Crores to Rs. 76 Crores, down 8.4 percent and net profit has increased from Rs. 76 Crores to Rs. 78 Crores, up 2.6 percent 

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Infra Stock Jumps 7% After It Secures ₹3,000 Cr Pharma Park Project in Maharashtra appeared first on Trade Brains.